Professional development Vacancies

Tritace® (ramipril)

19.09.2013 Updated 22.10.2019 16915 views

By MoH of Ukraine order No. 801 of 13.09.13, the instructions for medical use (hereinafter – the instructions) of the original (reference) medicinal product containing ramipril, namely Tritace®, tablets, were approved, with amendments and additions to the following sections of the instructions: “Contraindications,” “Adverse reactions,” “Use during pregnancy or breastfeeding,” “Special precautions for use,” “Interaction with other medicinal products and other forms of interaction.”

List of medicinal products containing ramipril as an active ingredient, authorized for medical use in Ukraine.